Choosing life sciences

OXFORD - Hoechst AG's announcement last week that it will shed its chemistry businesses and focus on biology is just the latest event in a phenomenon that finds chemical industry CEOs retraining

Read the full 320 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE